NeuroNano Pharma, Inc. logo

NeuroNano Pharma, Inc.

NeuroNano Pharma is a biopharmaceutical company developing a novel class of highly selective targeted nanotherapeutics for central nervous system diseases. NeuroNano Pharma develops technologies for delivering macro-molecules across the blood-brain barrier. NeuroNanos patented nano-polymers combine with peptides and proteins for several CNS indications.

NEURONANO in-licensed a portfolio of over 30 groundbreaking inventions on an exclusive and worldwide basis from University of Nebraska Medical Center, St. Louis University, University of Washington, and University of North Carolina at Chapel Hill.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://neuronanopharma.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3110 Edwards Mill Road, Suite 300, NC 27612
Raleigh
United States
Email
Contact Number
+1 919-225-9022

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

NEURONANO has perfected a series of formulation and delivery technologies that when used with current or newly discovered compounds can 1) preserve even very fragile biologics as they traverse the body, 2) improve the transport of polypeptides, proteins, hormones, enzymes and small molecules across cell membranes and tissue barriers, including the blood brain barrier, and 3) improve the release of drugs encapsulated in liposomes.